The FDA is holding a public hearing on the use of fecal microbiota transfer (FMT) to treat a bacterial infection. Are they paving the way to hand FMT to Big Pharma? The FDA announced a public meeting for November 4 of this year. The stated purpose of the meeting is to gather scientific information regarding the use of FMT to treat Clostridium difficile (C. diff) infections that are resistant to standard therapies. We fear that the FDA will use this tragedy to turn FMT into a drug, turning an inexpensive treatment into a pharmaceutical money maker.

Read full story...